Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.58 |
| ▸ | BACE1 | P56817 | 5/20 | 0.56 |
| ▸ | NPY4R | P50391 | 8/20 | 0.56 |
| ▸ | NPY1R | P25929 | 5/20 | 0.56 |
| ▸ | NPY2R | P49146 | 4/20 | 0.56 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.56 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.55 |
| ▸ | TFPI | P10646 | 1/20 | 0.54 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.54 |
| ▸ | CTSB | P07858 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31670468 | 0.94 | NPY4R (0.58) | KEAP1BACE1NPY4RNPY1RNPY2R | |
| SCHEMBL29570001 | 0.93 | NPY4R (0.58) | KEAP1BACE1NPY4RNPY1RNPY2R | |
| SCHEMBL31670482 | 0.93 | NPY4R (0.62) | KEAP1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31256690 | 0.91 | NPY4R (0.59) | KEAP1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29568582 | 0.90 | NPY4R (0.60) | KEAP1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31670461 | 0.89 | NPY4R (0.55) | KEAP1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30175896 | 0.89 | BACE1 (0.68) | BACE1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29486226 | 0.88 | NPY4R (0.69) | BACE1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29406011 | 0.88 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5RTFPI | |
| SCHEMBL31670460 | 0.88 | ERAP2 (0.56) | OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250332261-A1 | Payload-Polymer-Protein Conjugates | GLYKOS FINLAND OY (FI) | 2025-10-30 | — | — | US | disclosed |
| EP-3166638-B1 | PAYLOAD-POLYMER-PROTEIN CONJUGATES | GLYKOS FINLAND OY (FI) | 2025-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250332261-A1 | Payload-Polymer-Protein Conjugates | TXLNA, DDOST, CD44 | KEAP1 2932/4885BACE1 4866/4885NPY4R 2312/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.